Debashis Dutta

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Cerebrospinal Fluid

Endothelial Cells

Top Venues

Science signaling

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Sumita Raha, Debashis Dutta, Ramesh K Paidi, Kalipada Pahan
Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12 , 2791. Cells 13 (16) (2024)
Sumita Raha, Debashis Dutta, Ramesh K Paidi, Kalipada Pahan
Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12 , 2791. Cells 13 (16) (2024)
Moumita Majumder, Debashis Dutta
Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration. Cells 13 (13) (2024)
Moumita Majumder, Debashis Dutta
Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration. Cells 13 (13) (2024)
Ramesh K Paidi, Malabendu Jana, Rama K Mishra, Debashis Dutta, Kalipada Pahan
Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. Journal of immunology (Baltimore, Md. : 1950) 207 (10) (2021)
Sumita Raha, Arunava Ghosh, Debashis Dutta, Dhruv R Patel, Kalipada Pahan
Activation of PPARα enhances astroglial uptake and degradation of β-amyloid. Science signaling 14 (706) (2021)